GABA and homovanillic acid in the plasma of schizophrenic and bipolar i patients

Neurochemical Research

Volumn 35, Issue 2, 2010, Pages 247-253

  Arrúe, Aurora ^a   Dávila, Ricardo ^a   Zumárraga, Mercedes ^a   Basterreche, Nieves ^a   González Torres, Miguel A ^b   Goienetxea, Biotza ^a   Zamalloa, Maria I ^a   Anguiano, Juan B ^c   Guimón, José ^d  

^a Hospital Psiquiatrico de Zamudio   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c Centro de Salud Mental de Ortuella   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bipolar disorder; Gamma aminobutyric acid; Homovanillic acid; Plasma; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; HOMOVANILLIC ACID;

4 AMINOBUTYRIC ACID BLOOD LEVEL; ADULT; ARTICLE; BIPOLAR I DISORDER; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC REGULATION; HOMOVANILLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; DOPAMINE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOMOVANILLIC ACID; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 76749172298     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0048-z     Document Type: Article

References (52)

1. SE Hyman 2008 A glimmer of light for neuropsychiatric disorders Nature 455 890 893 10.1038/nature07454 18923510
2. M Davidson MF Losonczy RC Mohs, et al. 1987 Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients Neuropsychopharmacology 1 17 23 10.1016/0893-133X(87)90005-4 3509064 (Pubitemid 19125244)
3. PE Konicki RR Owen RE Litman, et al. 1991 The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients Life Sci 48 1411 1416 10.1016/0024-3205(91)90438-H 2008157
4. R Kaminski P Powchick PA Warne, et al. 1990 Measurement of plasma homovanillic acid concentrations in schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 14 271 287 10.1016/0278-5846(90)90016-A 2193315 (Pubitemid 20191892)
5. PM Laduron JE Leysen 1979 Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity Biochem Pharmacol 28 2161 2165 10.1016/0006-2952(79)90198-9 496998 (Pubitemid 9237078)
6. F Petty G Kramer M Feldman 1987 Is plasma GABA of peripheral origin? Biol Psychiatry 22 725 732 10.1016/0006-3223(87)90204-6 2885038 (Pubitemid 17101481)
7. F Petty 1994 Plasma concentrations of γ-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Biol Psychiatry 39 278 284 10.1016/0006-3223(95)00141-7
8. W Löscher 1979 GABA in plasma and cerebrospinal fluid of different species: effects of γ-acetylenic GABA, γ-vinyl GABA and sodium valproate J Neurochem 38 293 295 10.1111/j.1471-4159.1982.tb10886.x
9. VS Uhlhaas H Lanage J Wappenschmidt, et al. 1986 Free and conjugated CSF and plasma GABA in Huntington′s chorea Acta Neurol Scand 74 261 265 3028028
10. F Petty GL Kramer M Fulton, et al. 1993 Low plasma GABA is a trait-like marker for bipolar illness Neuropsychopharmacology 9 125 132 8216695
11. B Adinoff GL Kramer F Petty 1995 Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal Psychiatry Res 59 137 144 10.1016/0165-1781(95)02739-4 8771228 (Pubitemid 26024510)
12. D Pickar R Labarca M Linnoila, et al. 1984 Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients Science 225 954 957 10.1126/science.6474162 6474162
13. R Davila E Manero M Zumarraga, et al. 1988 Plasma homovanillic acid as a predictor of response to neuroleptics Arch Gen Psychiatry 45 564 567 3377643
14. MB Bowers Jr ME Swigar PI Jatlow, et al. 1989 Plasma catecholamine metabolites and treatment response at neuroleptic steady state Biol Psychiatry 25 734 738 10.1016/0006-3223(89)90245-X 2923935 (Pubitemid 19101990)
15. M Davidson RS Kahn P Powchik, et al. 1991 Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation Arch Gen Psychiatry 48 73 76 1670618
16. AI Green MY Alam RA Boshes, et al. 1993 Haloperidol response and plasma catecholamines and their metabolites Schizophr Res 10 33 37 10.1016/0920- 9964(93)90074-S 8369230 (Pubitemid 23211836)
17. S Kakihara R Yoshimura K Shinkai, et al. 2005 Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6 Int Clin Psychopharmacol 20 71 78 10.1097/00004850-200503000-00002 15729081 (Pubitemid 40354395)
18. M Markianos M Panas N Kalfakis, et al. 2009 Plasma homovanillic acid and prolactin in Huntington's disease Neurochem Res 34 917 922 10.1007/s11064-008- 9851-1 18841471
19. F Fortunati C Mazure A Preda, et al. 2002 Plasma catecholamine metabolites in antidepressant-exacerbated mania and psychosis J Affect Disord 68 331 334 10.1016/S0165-0327(00)00327-X 12063160 (Pubitemid 34628337)
20. R Yoshimura Y Nakano H Hori, et al. 2006 Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders Hum Psychopharmacol 21 433 438 10.1002/hup.804 17029305 (Pubitemid 44660182)
21. CM Mazure MB Bowers 1998 Pretreatment plasma HVA predicts neuroleptic response in manic psychosis J Affect Disord 48 83 86 10.1016/S0165-0327(97) 00159-6 9495606 (Pubitemid 28078975)
22. JC Chou P Czobor I Tuma, et al. 2000 Pretreatment plasma HVA and haloperidol response in acute mania J Affect Disord 59 55 59 10.1016/S0165-0327(99)00134-2 10814771 (Pubitemid 30256238)
23. N Basterreche R Dávila M Zumárraga, et al. 2008 Biological correlates of the congruence and incongruence of psychotic symptoms in patients with Type 1 bipolar disorder Neuropsychobiology 58 111 117 10.1159/000170391 18997477
24. M Zumárraga R Dávila N Basterreche, et al. 2009 Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients Pharmacol Res 59 269 272 10.1016/j.phrs.2008.12.007 19162188
25. F Petty AD Sherman 1984 Plasma GABA levels in psychiatric illness J Affect Disord 6 131 138 10.1016/0165-0327(84)90018-1 6233345 (Pubitemid 14135649)
26. AW Goddard M Narayan SW Woods, et al. 1996 Plasma levels of gamma-aminobutyric acid and panic disorder Psychiatry Res 63 223 225 10.1016/0165-1781(96)02963-0 8878319 (Pubitemid 26276614)
27. KL Behar DL Rothman KF Petersen, et al. 1999 Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients Am J Psychiatry 156 952 954 10360140
28. G Sanacora GF Mason DL Rothman, et al. 1999 Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy Arch Gen Psychiatry 56 1043 1047 10.1001/archpsyc.56.11.1043 10565505 (Pubitemid 29526389)
29. HM Emrich D von Zerssen W Kissling, et al. 1980 Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders Arch Psychiatr Nervenkr 229 1 16 10.1007/BF00343800 6778456 (Pubitemid 10029295)
30. DW Volk MC Austin JN Pierri, et al. 2000 Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia Arch Gen Psychiatry 57 237 245 10.1001/archpsyc.57.3.237 10711910
31. A Guidotti J Auta JM Davis, et al. 2005 GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon Psychopharmacology 180 191 205 10.1007/s00213-005-2212-8 15864560 (Pubitemid 40909664)
32. WM Bullock K Cardon J Bustillo, et al. 2008 Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients Am J Psychiatry 165 1594 1603 10.1176/appi.ajp.2008.07121845 18923069
33. DP van Kammen F Petty ME Kelley, et al. 1998 GABA and brain abnormalities in schizophrenia Psychiatry Res 82 25 35 10.1016/S0925-4927(98)00006-7 9645548 (Pubitemid 28254991)
34. A Wassef J Baker LD Kochan 2003 GABA and schizophrenia: a review of basic science and clinical studies J Clin Psychopharmacol 23 601 640 10.1097/01.jcp.0000095349.32154.a5 14624191 (Pubitemid 37443192)
35. G Winterer 2006 Cortical microcircuits in schizophrenia-the dopamine hypothesis revisited Pharmacopsychiatry 39 68 71 10.1055/s-2006-931498 (Pubitemid 43357110)
36. A Lautin B Angrist M Stanley, et al. 1980 Sodium valproate in schizophrenia: some biochemical correlates Br J Psychiatry 137 240 244 10.1192/bjp.137.3.240 6777010
37. MS Reid WT O'Connor M Herrera-Marschitz, et al. 1990 The effects of intranigral GABA and dynorphin a injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors Brain Res 519 255 260 10.1016/0006-8993(90)90086-Q 1975763 (Pubitemid 20199696)
38. F Petty M Fulton GL Kramer, et al. 1999 Evidence for the segregations of a major gene for human plasma GABA levels Mol Psychiatry 4 587 589 10.1038/sj.mp.4000569 10578242
39. P Brambilla J Perez F Barale, et al. 2003 GABAergic dysfunction in mood disorders Mol Psychiatry 8 712 737
40. M Zumárraga I Andía R Dávila, et al. 1994 Homovanillic acid in plasma determined by HPLC with direct injection of plasma filtrates Clin Chem 40 2119 2120 7955397
41. American Psychiatric Association Washington (2000) Diagnostic and statistical manual of mental disorders (DSM-IV-TR). Washington, American Psychiatric Association
42. First MB, JBW W, Spitzer RL (eds) (1997) Structured clinical interview for the diagnostic and statistical manual, 4th edn. American Psychiatric Press, Washington DC
43. GK Thaker 2008 Neuropsychiological endophenotypes across bipolar and schizophrenia psychosis Schizophr Bull 34 760 773 10.1093/schbul/sbn049 18502737 (Pubitemid 351957568)
44. WH Berrettini JI Nurnberger Jr TA Hare, et al. 1983 Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate Biol Psychiatry 18 185 194 6403063
45. TL Perry SJ Kish J Buchanan, et al. 1979 Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients Lancet 3 237 239 10.1016/S0140-6736(79)90767-0
46. EG Spokes NJ Garrett MN Rossor, et al. 1980 Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects J Neurol Sci 48 303 313 10.1016/0022-510X(80)90103-3 6449563 (Pubitemid 11216871)
47. ER Korpi JE Kleinman SI Goodman RJ Wyatt 1987 Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients Psychiatry Res 22 291 301 10.1016/0165-1781(87)90108-9 2893404 (Pubitemid 18016504)
48. M Toru S Watanabe H Shibuya, et al. 1988 Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients Acta Psychiatr Scand 78 121 137 10.1111/j.1600-0447.1988.tb06312.x 2906213
49. FM Benes SL Vincent R Molloy, et al. 1996 Increased interaction of dopamine-immunoreactive varicosities with GABA neurons of rat medial prefrontal cortex occurs during the postweanling period Synapse 23 237 245 10.1002/(SICI)1098-2396(199608)23:4<237::AID-SYN1>3.0.CO;2-8 8855508 (Pubitemid 26262385)
50. M Akil JN Pierri RE Whitehead, et al. 1999 Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects Am J Psychiatry 10 1580 1589
51. KL Noblett EF Coccaro 2005 Molecular genetics of personality Curr Psychiatry Rep 7 73 80 10.1007/s11920-005-0028-1 15717990
52. P Lichtenstein BH Yip C Björk, et al. 2009 Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study Lancet 373 234 239 10.1016/S0140-6736(09)60072-6 19150704